US 9433686
Methods for treating castration resistant prostate cancer and metastasis by reducing B-cell number and/or function
granted A61KA61K2039/505A61K31/381
Quick answer
US patent 9433686 (Methods for treating castration resistant prostate cancer and metastasis by reducing B-cell number and/or function) held by The Regents of the University of California expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K2039/505, A61K31/381, A61K31/437, A61K38/1709